# a Prospective Randomised Study Evaluating the Efficacy of Intranasal Midazolam and Dexmedetomidine as a Sedative Agent in Management of Mandible Fracture

> **NCT07502651** · EARLY_PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Postgraduate Institute of Dental Sciences Rohtak** · enrollment: 32 (estimated)

## Conditions studied

- Sedation

## Interventions

- **DRUG:** Midazolam (Intranasal)
- **DRUG:** Dexmedetomidine (Intranasal)

## Key facts

- **NCT ID:** NCT07502651
- **Lead sponsor:** Postgraduate Institute of Dental Sciences Rohtak
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-05-25
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-04-25
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07502651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07502651, "a Prospective Randomised Study Evaluating the Efficacy of Intranasal Midazolam and Dexmedetomidine as a Sedative Agent in Management of Mandible Fracture". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07502651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*